 | • レポートコード：D0MOR-NV032 • 出版社/出版日：Mordor Intelligence / 2020年10月30日 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、血管塞栓術の世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、塞栓術別（コイル塞栓術、非コイリングデバイス）分析、用途別（末梢血管疾患、腫瘍、神経、泌尿器科、その他）分析、地域別分析、競争状況、投資分析、市場機会・将来動向などを整理しました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・血管塞栓術の世界市場規模：塞栓術別（コイル塞栓術、非コイリングデバイス） ・血管塞栓術の世界市場規模：用途別（末梢血管疾患、腫瘍、神経、泌尿器科、その他） ・血管塞栓術の世界市場規模：地域別 ・競争状況 ・投資分析 ・市場機会・将来動向 |
Vascular Embolization Market – Growth, Trends, and Forecast (2020 – 2025)
The Vascular Embolization Market is expected to register a CAGR of 5.8% during the forecast period. Vascular embolization is a procedure, in which an embolic agent is injected into the blood vessel to close them and stop the blood flow to a targeted area. Embolization procedure is advantageous compare to other procedures due to minimally invasive in nature, faster recovery time, minimal risk of infection, no scarring, and high success rate compared to other procedures. Some of the embolic agents used in the vascular embolization are microspheres, embolic coils, embolic plug systems, liquid embolic agents. Some of the supportive devices used for vascular embolization are detachable balloons, guidewires and microcatheters.
According to American Heart Association, coronary artery disease accounts for the highest number of deaths in the United States, affecting more than 13 million people. Every year, nearly 610,000 people die of heart disease in the United States, 1 in every 4 deaths. In addition, according to World Health Organization (WHO), in the year 2016, worldwide about 31% of deaths are due to cardiovascular diseases (CVDs).
Increasing prevalence of vascular diseases, technological advancements in embolization products and procedures, increasing research and development activities and growing demand for minimally invasive procedures are the key driving factors in vascular embolization market.
[Key Market Trends]
Coiling Devices Segment is Expected to Hold a Major Market Share in the Vascular Embolization Market
• Coils are permanent embolization agents that cause mechanical vessel occlusion through thrombus formation. The coiling devices segment includes detachable coils and pushable coils.
• According to World Health Organization (WHO), globally cardiovascular diseases (CVDs) are the number 1 cause of death, an estimated 17.9 million each year suffer with cardiovascular diseases. Four out of 5 cardiovascular deaths are due to strokes and heart attacks, and one third of deaths occur prematurely in people under 70 years of age.
• Coiling devices segment holds a significant market share in the vascular embolization market and is anticipated to show similar trend over the forecast period due to high prevalence rate of cancer and vascular diseases.
• Technological advancements and innovations in embolization devices and increasing research and development activities have increased their adoption in the treatment of chronic conditions such as cancer and vascular diseases are the key driving factors in the coiling devices segment.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major market share in the global vascular embolization market due to increasing prevalence of cancer and vascular related diseases and increasing research and development activities in this region. According to the Centers for Disease Control and Prevention (CDC), in the United States, approximately 365,914 people died due to coronary heart disease in the year 2017. About 18.2 million adults age 20 and older have Coronary heart disease. Moreover, about 2 in 10 deaths are due to Coronary heart disease in adults less than 65 years old. Furthermore, increase in technological advancements and new product launches, and presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.
[Competitive Landscape]
The Vascular Embolization Market is fragmented competitive and consists of a several major players. Some of the players have used various strategies such as expansions, new product launches, acquisitions, and others to increase their footprints in this market. Some of the companies which are currently dominating the market are Medtronic Plc, Cook Medical, Stryker Corporation, Boston Scientific Corporation, Abbott Laboratories, Johnson and Johnson (cerenovus), Merit Medical Systems Inc, Penumbra Inc, Terumo Corp and Shape Memory Medical Inc.
[Reasons to Purchase this report]
• The market estimate (ME) sheet in Excel format
• 3 months of analyst support
• The Thailand Motor Insurance Market is estimated to grow at a CAGR of approximately 6% during the forecast period.
• As of September 2019, the direct premium of compulsory motor insurance was 13.99 billion THB and voluntary motor insurance 91.2 billion THB. Overall Motor insurance direct premium was 10.51 billion THB and it holds 59.27% share in the overall non-life insurance segment. The number of policies has been increased and totaled to 25 billion in compulsory motor insurance and 7.7 billion in voluntary motor insurance. The Thai non-life insurance market is highly competitive, the top 10 insurers have an aggregate market share of 60%. the combined operating ratio (COR) for motor insurance has increased in recent years and stood at 106.7% for 36 companies in 2018. The contrasts with the COR (combined operating ratio) for non-motor businesses, such as fire, marine and other lines which were 81.5%.
• Competition is expected to increase with the increasing prominence of technology. Moreover, to maintain underwriting efficiency and retain market share, most insurers are actively developing their own technology, adopting InsurTech, or partnering with brokers on established InsurTech platforms, motor insurance and health insurance companies are the most active in these developments.
Key Market Trends
Growing non-life insurance:
Non-life insurance premium growth in Thailand in 2018 was 6.1%. The Thai life insurance market has risen in previous years as an economic bright spot, with both premiums and policy penetration rates on the rise.
Motor Insurance hold highest share in Non-Life Insurance segment:
The country produced 2 million units in 2018 and exports more than half of its output to more than 100 countries. The industry has seen an 8.7 %year-on-year growth in 2018 and just over 1 million units were sold domestically. the Thai government is persistently trying to encourage the manufacturing of EVs (Electric Vehicles) and high-tech auto parts through the promotion of BOI (Board of Investment of Thailand) incentive packages. In 2018, the government approved projects to produce HEVs (Hybrid Electric Vehicles) and batteries by Nissan Motor Co and Honda Motor Co valued up to THB 28 billion. Meanwhile, Mazda Motor Co was granted investment privilege to manufacture HEVs and has decided to apply for production of full EVs in Thailand.
[Competitive Landscape]
The report covers the major players operating in the Thailand Motor Insurance Market. The market is Consolidated due to top companies hold approximately 60% market share. Thaivivat, an insurance company in Thailand, has partnered with telco AIS to draw uninsured drivers across the country. The idea is to provide a kind of coverage that is affordable through a unique product that is the first of its kind in the world.
[Reasons to Purchase this report]
• The market estimate (ME) sheet in Excel format
• 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Vascular Diseases
4.2.2 Technological Advancements in Embolization Products and Procedures
4.2.3 Increasing Research and Development Activities
4.3 Market Restraints
4.3.1 High Costs Associated with Embolization Procedures
4.3.2 Stringent Regulatory Norms
4.3.3 Complications Associated with Embolization Procedures
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Embolization Technique
5.1.1 Coiling Devices
5.1.2 Non-coiling Devices
5.2 By Application
5.2.1 Peripheral Vascular Disease
5.2.2 Oncology
5.2.3 Neurology
5.2.4 Urology
5.2.5 Other Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medtronic Plc
6.1.2 Cook Medical
6.1.3 Stryker Corporation
6.1.4 Boston Scientific Corporation
6.1.5 Abbott Laboratories
6.1.6 Johnson and Johnson (cerenovus)
6.1.7 Merit Medical Systems Inc
6.1.8 Penumbra Inc
6.1.9 Terumo Corp
6.1.10 Shape Memory Medical Inc
7 MARKET OPPORTUNITIES AND FUTURE TRENDS